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Abstract 
 
Background: Chronic supportive otitis media (CSOM) is one of the commonest illnesses in ENT practice. This 
study was conducted to find out the various aerobic microorganisms associated with CSOM and their current 
antimicrobial susceptibility patterns to commonly used antimicrobials. 
 
Methods: samples were collected from 117 clinically diagnosed cases of CSOM and processed according to 
standard protocols.  
 
Results: Out of 117 CSOM cases, 105 (86%) showed positive bacterial culture. The Staphylococcus aureus was 
the commonest aerobic isolate in CSOM. The sensitivity of Staphylococci spp. to commonly used antimicrobials 
varied from 27.2% for cefixime to 95.5% for gentamicin and coagulase positive. Pseudomonas isolates showed 
complete (100%) resistance to amoxicillin/clavulanate (co-amoxiclave), cloxacillin and cefixime, and high sensi-
tivity to ciprofloxacin (95%) and cephalexin (90%).  
 
Conclusion: An appropriate knowledge of antibacterial susceptibility of microorganisms would contribute to a 
rational antibiotic use and the success of treatment for chronic supportive otitis media. 
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Introduction 
 
Chronic supportive otitis media (CSOM) is the chron-
ic inflammation of the middle ear and mastoid muco-
sa in which the tympanic membrane is perforated and 
discharges of grayish-white, homogeneous, turbid, 
and viscous secretions are present.
1-3 CSOM most 
often occurs in the first 5 years of life, and is common 
in developing countries, in special populations such 
as children with craniofacial anomalies and in certain 
racial groups.
2,4 
The aerobic microorganisms most frequently isolat-
ed in CSOM are Pseudomonas aeruginosa, Staphylo-
coccus aureus, Gram-negative organisms such as Pro-
teus spp., Klebsiella spp., and Escherichia spp., Hae-
mophilus influenzae, and Moraxella catarrhalis.
1,3,5 The 
most frequently isolated anaerobic organisms were Bac-
teroides spp. and Fusobacterium spp.
5,6 
Since the bacteriology and antimicrobial susceptibil-
ity of CSOM infections were not determined in Iran, this 
study was performed to evaluate the antimicrobial sus-
ceptibility patterns among aerobic bacteria isolated from 
CSOM patients in ENT clinics in Kerman, Iran. 
 
 
Materials and Methods 
 
Samples were collected from 117 clinically diagnosed 
cases of CSOM by ENT specialists at private clinics 
and ENT educational clinics of Kerman University of 
Medical Sciences in Iran and processed according to 
standard protocols. CSOM was defined as otorrhea 
through a perforated tympanic membrane present for 
at least 2-6 weeks.
2,3 Exclusion criteria were current 
febrile illness, current antibiotic use or use in the   
 
 
 
 
*Correspondence: Gholamreza Sepehri, PhD, Professor of Phar-
macology, Kerman Neuroscience Research Center, Jahad Blvd, 
PO Box: 76198-13159, Kerman, Iran. Tel: +98-341-2264196, 
Fax: +98-341-2264196, e-mail: gsepehri@yahoo.com 
Received: May 22, 2011  Accepted: August 12, 2011 Mozafari Nia et al. 
 
WWW.ircmj.com Vol 13 December 2011  892
preceding 2 weeks, need for renal dialysis, recent ear 
surgery or an in-situ grommet or tympanostomy tube, 
mastoid surgery in the preceding 12 months, congeni-
tal ear or hearing problems, obstructed middle ear 
(eg, polyp) and pregnancy. 
An ear swab was obtained by inserting a sterile 
swab deep in the ear canal and the discharges were 
added to Stuart transport medium and transported to a 
microbiology test laboratory. Organisms were identi-
fied using standard methods and API identification 
system (bioMérieux, Basingstoke, UK).
7 
Gram positive and gram-negative bacterial sensi-
tivity of isolates to commonly used antimicrobials 
(gentamicin, ciprofloxacin, amoxicillin/clavulanate, 
(co-amoxiclave), cloxacillin, cefixime and cephalex-
in) were investigated by disk diffusion method using 
NCCLS guidelines.
8 Data were analyzed by SPSS 
software (Version 16, Chicago, IL, USA).  
 
 
Results 
 
The culture samples of the 105 out of 117 patients 
were positive, yielding 128 bacteria. Fungi were iso-
lated in 21 patients (24.57%) and 12 patients 
(14.04%) had neither bacteria nor fungi infections 
(Table 1).  Staphylococci species (50.3%) were the 
most prevalent microorganisms isolated followed by 
Pseudomonas aeruginosa (23.4%) (Table 1). 
Table 2 shows the resistance rates of the main 
isolated pathogens (Staphylococci  species and 
Pseudomonas aeruginosa, proteus and Klebsiella) 
from CSOM patients to commonly prescribed an-
timicrobials. The co-infection with several bacterial 
species (including Staphylococcus aureus and 
Pseudomonas aeruginosa) was seen in 11 (12.9%) 
patients (Table 1). 
Sensitivity of coagulase negative Staphylococci 
spp. to commonly used antimicrobials varied from 
33.3% for cefixime to 57.1% for cloxacillin and 
cephalexin (Table 2). Pseudomonas isolates showed 
complete (100%) resistance to amoxicil-
lin/clavulanate (co-amoxiclave), cloxacillin and cefix-
ime, but it showed high sensitivity to ciprofloxacin 
(95%) and cephalexin (95%) (Table 2). Proteus spp. 
showed relatively high sensitivity to ciprofloxacin 
(80%) and gentamicin (60%). Also co-amoxiclave, 
ciprofloxacin and gentamicin showed good antibacte-
Table 1: The bacteriological findings obtained from 117 CSOM
a patients
Species  No. of isolates % of isolates 
No growth  12  14.04 
Coagulase (+) Staphylococcus 22  25.74 
Coagulase (-) Staphylococcus  21 24.57 
Pseudomonas aeruginosa 20  23.40 
Escherichia coli  7 8.19 
Streptococcus  6 7.02 
Proteus   5  5.85 
Klebsiella   5  5.85 
Enterococcus 3  3.51 
Citrobacter 2 2.34 
Enterobacter 1  1.17 
Fungi 21  24.57 
Mixed Infection  11 12.9 
a CSOM: Chronic suppurative otitis media.  
 
Table 2: Antibiotic susceptibility of isolated microorganisms from otorrhea in 117 CSOM patients to commonly 
used antimicrobials
a. 
Species CP  CFM CO-AMOX CLOX GM CF
Coagulase (+) Staph  85.4 27.2 63.6  81.8  95.5  90.9 
Coagulase (-) Staph  52.4 33.3 52.4  57.1  47.6  57.1 
Pseudomonas  95  0  0 0 85 5 
Proteus  80 60 0  0  60  40 
Klebsiella  60 20 80  20  60  40 
a CSOM: Chronic suppurative otitis media. CP: Ciprofloxacin, CFM: Cefixime, CO-AMOX: Amoxicillin/Clavulanate 
(Co-amoxiclave), CLOX: Cloxacillin, GM: Gentamicin, CF: Cephalexin. Antimicrobial susceptibility from CSOM 
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rial activity against Klebsiella spp. (Table 2).  
Discussion 
 
The results of this study showed that Staphylococcus 
aureus was the commonest aerobic isolate in CSOM 
followed by Pseudomonas aeruginosa which is in 
agreement with the reports of some other investiga-
tors in different parts of the worlds, however, others 
reported that Pseudomonas aeruginosa was the com-
menest isolated microorganism in CSOM pa-
tients.
1,3,5,9 
Streptococcus, Proteus, Klebsiella, Enterococcus, 
Citrobacter, Enterobacter and fungi were isolated in 
some CSOM patients which is comparable to the re-
sults of other investigators.
5,6 The sensitivity of coag-
ulase negative Staphylococci spp. to commonly used 
antimicrobials varied from 27.2% for cefixime to 
57.1% for cloxacillin and cephalexin .However, co-
agulase positive Staphylococci spp. were more sensi-
tive to commonly used antimicrobials and showed 
high sensitivity rates to gentamicin (95.5%), 
cephalexin (90.9%) and ciprofloxacin (85.4%). Clini-
cal resistance of Staphylococci spp. to penicillin and 
other antimicrobial agents is now a problem through-
out the world.
10-12  
Staphylococci spp. sensitivity to ciprofloxacin is in 
agreement with other reports and most of the investi-
gators reported high sensitivity rate for Staphylococci 
spp. to fluoroquinolones such as ofloxacin and ciprof-
loxacin.
5,10,13 Pseudomonas isolates showed complete 
(100%) resistance to amoxicillin/clavulanate (co-
amoxiclave), cloxacillin and cefixime which is in 
contradictory to other reports, although some other 
investigators showed high resistance rate for Pseu-
domonas isolates to beta-lactam antibiotics.
1,5,6,14  
Pseudomonas showed high sensitivity to ciprof-
loxacin (95%) and it was relatively sensitive to gen-
tamicin (85%). High fluoroquinolones antibacterial 
activity against Pseudomonas isolates  was reported 
by others, although resistant strains of Pseudomonas 
isolates to fluoroquinolones were detected in other 
studies.
1,5,10, 13  
Coagulase positive Staphylococci and Pseudomo-
nas showed high sensitivity to gentamicin which is 
comparable to the results of Gul et al. (58%).
1,15 Oth-
ers reported a relatively low bacterial resistance to 
both  coagulase positive Staphylococci  and  Pseudo-
monas isolates.
14 The resistance to commonly used 
antimicrobials in Iran has been reported by other in-
vestigators too.
16-18  
In summary, the results of this study showed high 
resistance rate of  Staphylococci and Pseudomonas 
isolates from CSOM patients to ß- lactam and other 
commonly used antimicrobials. Therefore, an appro-
priate knowledge of antibacterial susceptibility of 
microorganisms may contribute to rational antibiotic 
use and the success of treatment for chronic support-
ive otitis media.  
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